I hadn't seen this posted (probably just missed it, because I would imagine someone would have found it before me...I'm kinda slow sometimes) but this is just one more thing I found online. It's the PGA Tour Anti Doping Program manual from 2009 (not sure if all of it is still current). Positive tests are not necessary when you confess to it, so I don't know why Vijay would have thought he'd be immune to any punishment.
(here's the link if you want to read the entire publication)
From Section 1 (page 3)
"If you are unsure of a product’s ingredients, you should not take that product until you are sure it does not contain any prohibited substance(s). In addition, the manufacturing and labeling of supplements are not subject to strict regulation, which may lead to a supplement containing a substance that is prohibited under the Program, even though that substance is not listed as an ingredient. In years past, positive test results in other sports have been attributed to the use of mislabeled supplements. Since taking a poorly labeled supplement is not a defense to a violation of the Program, you are urged to exercise caution and conduct appropriate research when using these products."
(also bolded in the source...apparently the PGA wanted to emphasize that point, huh?)
From Section 2, this is Subsection D. (paragraph 8 seems to be pretty clear)
The following constitute anti-doping rule violations under the Program:
(1) The presence of a Prohibited Substance or its Metabolites or Markers in a player’s sample.
(a) I t is each player’s personal duty to ensure that no Prohibited Substance enters his body. Players are responsible for any Prohibited Substance or its Metabolites or Markers found to be present in their samples. Accordingly, it is not necessary that intent, fault, negligence or knowing use on the player’s part be demonstrated in order to establish an anti-doping violation under Section D(1).
(b) S ufficient proof of an anti-doping rule violation under Section D(1) is established by either of the following: (1) an Adverse Analytical Finding upon analysis of the player’s A sample where the player waives analysis of the B sample or, (2) where the player’s B sample is analyzed, the analysis of the player’s B sample confirms the presence of the Prohibited Substance or its Metabolites or Markers found in the player’s A sample.
(c) E xcepting those substances for which a quantitative reporting threshold is specifically identified in the PGA TOUR Prohibited List, the presence of any quantity of a Prohibited Substance or its Metabolites or Markers in a player’s sample shall constitute an antidoping rule violation.
(d) As an exception to the general rule of Section D(1)(c), the PGA TOUR Prohibited List may establish special criteria for the evaluation of Prohibited Substances that can also be produced Endogenously.
(2) Use or Attempted Use by a player of a Prohibited Substance or a Prohibited Method. The success or failure of the use of a Prohibited Substance or Prohibited Method is not relevant. It is sufficient that the Prohibited Substance or Prohibited Method was Used or Attempted to be Used for an anti-doping rule violation to be committed.
(3) Refusing, or failing without compelling justification, to submit to sample collection after notification or otherwise evading sample collection.
(4) Tampering, or Attempting to Tamper, with any part of Doping Control.
(5) Possession by a player of any Prohibited Substance or Prohibited Method, unless the player establishes that the Possession is pursuant to a therapeutic use exemption granted in accordance with Section F (Therapeutic Use Exemptions) or other acceptable justification.
(6) Trafficking in any Prohibited Substance or Prohibited Method.
(7) Administration or Attempted administration to any player of any Prohibited Substance or Prohibited Method, or assisting, encouraging, aiding, abetting, covering up or any other type of complicity involving an anti-doping rule violation or any Attempted anti-doping rule violation.
(8) Admissions by a player of any of the conduct listed in Sections (1) - (7) above.
Section 2, Subsection H "Results Management", paragraph 5
"At such time as the Program Administrator determines that a player may have committed an anti-doping rule violation, the player shall be Notified of the potential violation. The player shall have seven (7) calendar days from such Notice to provide a written explanation to the Program Administrator. The Program Administrator shall consider any information submitted by the player and shall then decide whether to go forward with an anti-doping rule violation against the player. If the Program Administrator’s decision is to go forward with an anti-doping rule violation, the player shall be Notified of the sanction which will be imposed. That sanction will be imposed seven (7) calendar days after notification unless the player advises the Program Administrator in writing that he desires to appeal the Program Administrator’s decision to the Commissioner. If the player fails to appeal within the time specified, then the Program Administrator’s decision shall be final and not subject to any further challenge or appeal."
Section 2, Subsection I "Appeals to the Commissioner" includes the following
The PGA TOUR shall have the burden of establishing by a balance of probability that an antidoping rule violation occurred. Facts related to anti-doping rule violations may be established by any reliable means including, but not limited to, admissions, witness statements, documentary evidence, or conclusions drawn from longitudinal profiling or other analytical information which does not otherwise satisfy all of the requirements to establish a violation for Section D(1).
Section 2, Subsection K "Sanctions" lists all possible sanctions. Note, there is NO statement of leniency for first-time offenses as someone suggested. Each case is evaluated on its own merit (as they should be).
Edited by dave67az - 2/10/13 at 2:35pm
Sanctions on players may include:
(1) Disqualification, including loss of results, points, and prize money from the date the antidoping rule violation was found to occur forward.
(2) Ineligibility to participate in PGA TOUR competitions or other activities.
(a) The applicable period of Ineligibility for a first anti-doping rule violation under the Program, other than for Drugs of Abuse, shall be up to one year Ineligibility except in cases involving Trafficking, administration, or Aggravating Circumstances, where the sanction may be up to permanent Ineligibility.
(b) The applicable period of Ineligibility for a second anti-doping rule violation under the Program, other than for Drugs of Abuse, shall be up to five (5) years Ineligibility except in cases involving Trafficking, administration, or Aggravating Circumstances, where the sanction may be up to permanent Ineligibility.
(c) The applicable period of Ineligibility for a third anti-doping rule violation under the Program, other than Drugs of Abuse, shall be up to a permanent ban.
(3) A player committing an anti-doping rule violation under the Program may also be subject to the imposition of a fine in an amount up to $500,000.
(4) Sanctions for Drugs of Abuse shall include a PGA TOUR-approved plan of treatment and rehabilitation to be conducted at the player’s expense, in addition to or in lieu of Ineligibility and fines.
(5) I n applying these sanctions in a particular case, the Program Administrator and the Commissioner’s designee may, except for Drugs of Abuse, look for guidance to International Anti-Doping Standards.
(6) The PGA TOUR reserves the right to not impose any sanction if that sanction would benefit a player’s standing in any manner (e.g., rankings, points).
In rendering the final decision in a particular case, the Commissioner may depart from the sanction guidance in the International Anti-Doping Standards as he deems appropriate in a particular case.